JMI LABS IS NOW PART OF LEARN MORE

Activity of cefiderocol against carbapenem-resistant and molecularly characterized Enterobacterales isolates causing infections in hospitals in Europe and adjacent regions (2020–2023). Lead author: Rodrigo E. Mendes, presented at ESCMID Global 2025, April 14, Vienna, Austria

Poster #E0721

View Poster